Company Quick10K Filing
Energy Transfer Operating
10-Q 2020-03-31 Filed 2020-05-11
10-K 2019-12-31 Filed 2020-02-21
10-Q 2019-09-30 Filed 2019-11-07
10-Q 2019-06-30 Filed 2019-08-08
10-Q 2019-03-31 Filed 2019-05-09
10-K 2018-12-31 Filed 2019-02-22
10-Q 2018-09-30 Filed 2018-11-08
10-Q 2018-06-30 Filed 2018-08-09
10-Q 2018-03-31 Filed 2018-05-10
10-K 2017-12-31 Filed 2018-02-23
10-Q 2017-09-30 Filed 2017-11-08
10-Q 2017-06-30 Filed 2017-08-09
10-Q 2017-03-31 Filed 2017-05-04
10-K 2016-12-31 Filed 2017-02-24
10-Q 2016-09-30 Filed 2016-11-09
10-Q 2016-06-30 Filed 2016-08-04
10-Q 2016-03-31 Filed 2016-05-05
10-K 2015-12-31 Filed 2016-02-26
10-Q 2015-09-30 Filed 2015-11-05
10-Q 2015-06-30 Filed 2015-08-06
10-Q 2015-03-31 Filed 2015-05-07
10-K 2014-12-31 Filed 2015-02-26
10-Q 2014-09-30 Filed 2014-11-06
10-Q 2014-06-30 Filed 2014-08-07
10-Q 2014-03-31 Filed 2014-05-08
10-K 2013-12-31 Filed 2014-02-27
10-Q 2013-09-30 Filed 2013-11-07
10-Q 2013-06-30 Filed 2013-08-08
10-Q 2013-03-31 Filed 2013-05-09
10-K 2012-12-31 Filed 2013-03-01
10-Q 2012-09-30 Filed 2012-11-08
10-Q 2012-06-30 Filed 2012-08-02
10-Q 2012-03-31 Filed 2012-05-03
10-K 2011-12-31 Filed 2012-02-24
10-Q 2011-09-30 Filed 2011-11-03
10-Q 2011-06-30 Filed 2011-08-04
10-Q 2011-03-31 Filed 2011-05-05
10-K 2010-12-31 Filed 2011-02-23
10-Q 2010-09-30 Filed 2010-11-04
10-Q 2010-06-30 Filed 2010-08-04
10-Q 2010-03-31 Filed 2010-05-05
10-K 2009-12-31 Filed 2010-02-23
8-K 2020-05-11 Regulation FD, Exhibits
8-K 2020-04-30 Sale of Shares, Amend Bylaw, Exhibits
8-K 2020-03-31 Sale of Shares
8-K 2020-03-17 Regulation FD
8-K 2020-02-19 Regulation FD, Exhibits
8-K 2020-02-01 Sale of Shares
8-K 2020-01-22 Enter Agreement, Shareholder Rights, Amend Bylaw, Exhibits
8-K 2020-01-13 Regulation FD
8-K 2020-01-07 Enter Agreement, Exhibits
8-K 2020-01-01 Sale of Shares
8-K 2019-12-11 Regulation FD
8-K 2019-11-19 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2019-11-19 Regulation FD
8-K 2019-11-06 Regulation FD, Exhibits
8-K 2019-10-17
8-K 2019-09-25 Regulation FD
8-K 2019-09-03 Regulation FD
8-K 2019-08-13 Regulation FD
8-K 2019-08-07 Regulation FD, Exhibits
8-K 2019-07-02 Amend Bylaw, Exhibits
8-K 2019-06-17 Regulation FD
8-K 2019-05-13 Regulation FD
8-K 2019-05-08 Regulation FD, Exhibits
8-K 2019-04-25 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2019-04-17 Enter Agreement, Exhibits
8-K 2019-03-26 Regulation FD
8-K 2019-03-25 Enter Agreement, Other Events, Exhibits
8-K 2019-03-15 Other Events
8-K 2019-02-20 Regulation FD, Exhibits
8-K 2019-01-15 Enter Agreement, Exhibits
8-K 2019-01-08 Enter Agreement, Other Events, Exhibits
8-K 2019-01-07 Regulation FD
8-K 2019-01-04 Amend Bylaw, Exhibits
8-K 2018-12-04 Regulation FD
8-K 2018-11-13 Regulation FD
8-K 2018-11-07 Regulation FD, Exhibits
8-K 2018-10-19 Enter Agreement, Off-BS Arrangement, Exhibits
8-K 2018-10-18 Shareholder Vote, Other Events, Exhibits
8-K 2018-10-18 M&A, Sale of Shares, Shareholder Rights, Officers, Amend Bylaw, Regulation FD, Exhibits
8-K 2018-09-11 Regulation FD, Other Events, Exhibits
8-K 2018-09-04 Regulation FD
8-K 2018-08-14 Other Events
8-K 2018-08-14 Regulation FD
8-K 2018-08-08 Earnings, Exhibits
8-K 2018-08-01 Enter Agreement, Sale of Shares, Exhibits
8-K 2018-08-01 Regulation FD, Other Events, Exhibits
8-K 2018-07-23 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2018-07-18 Officers
8-K 2018-07-16 Enter Agreement, Exhibits
8-K 2018-06-18 Regulation FD
8-K 2018-06-05 Enter Agreement, Off-BS Arrangement, Other Events, Exhibits
8-K 2018-05-22 Regulation FD
8-K 2018-05-09 Earnings, Exhibits
8-K 2018-04-25 Shareholder Rights, Amend Bylaw, Exhibits
8-K 2018-04-23 Enter Agreement, Exhibits
8-K 2018-04-09 Regulation FD
8-K 2018-04-03 Enter Agreement, M&A, Regulation FD, Exhibits
8-K 2018-02-27 Regulation FD
8-K 2018-02-21 Earnings, Exhibits
8-K 2018-02-15 Officers
8-K 2018-02-06 Officers
8-K 2018-01-24 Other Events
8-K 2018-01-15 Enter Agreement, Regulation FD, Exhibits
8-K 2018-01-09 Regulation FD

Energy Transfer Operating Financials

ETP Metrics, Comps, Filings

Quarterly | Annual

Business

We (Energy Transfer Operating, L.P., a Delaware limited partnership, "ETO" or the "Partnership") are a consolidated subsidiary of Energy Transfer LP ("ET"). In October 2018, ET completed the merger of ETO with a wholly-owned subsidiary of ET in a unit-for-unit exchange (the "Energy Transfer Merger"), as discussed further below, at which time the Partnership changed its name from Energy Transfer Partners, L.P. to Energy Transfer Operating, L.P.

We are managed by our general partner, Energy Transfer Partners GP, L.P. (our "General Partner" or "ETP GP"), and ETP GP is managed by its general partner, Energy Transfer Partners, L.L.C. ("ETP LLC"), which is owned by ET. The primary activities in which we are engaged, all of which are in the United States, are as follows:

-natural gas midstream and intrastate transportation and storage;


Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
OWC Pharmaceutical Research (OWCP) 0 0% -0.2 362% 2 1 0 0 6 6 -1
Headhunter Group (HHR)
United States Short Oil Fund (DNO) 0 -0% 0.0 0 0 -1 0 -2 -2 -0
Immune Therapeutics (IMUN) 0 0.0 -29,381% 0 13 0 0 -2 -2 -0
Juniper Industrial (JIH)
PositiveID Corp (PSID)
Live Current Media (LIVC) 0 2.8 -26% 0 0 0 0 -0 -0 -0
Sun Pacific Holding (SNPW) 0 30% -17.5 -20% 7 11 0 0 -1 -0 6
Digatrade Financial (DIGAF) 0 0% 1 1 0 0 0 0 0
Lingerie Fighting Championships (BOTY) 0 -49% 0.2 -8,950,200% 0 -0 0 -0 -0
New Century Resources (NCRE) 0 0.0 0 0 0 0 -0 -0 -0
Arete Industries (ARET)
Renewable Energy Acquisition (REAC) 0 0.0 2,353,600% 0 0 -0 -0 -0
Sundial Growers (SNDL)
Energy Transfer Operating (ETP) 0 27% 5.8 4% 95,247 59,636 40,493 10,886 3,786 8,016 46,523
Blue Line Protection Group (BLPG) 0 40% 0.0 -189% 2 6 3 1 -3 -3 -0
ABCO Energy (ABCE) 0 38% 0.1 -173% 0 1 2 1 -1 -1 -0
Guided Therapeutics (GTHP) 0 332% 0.1 1,462% 0 16 0 0 6 7 0
Endonovo Therapeutics (ENDV) 0 73% -0.8 -301% 3 20 0 0 -10 -10 7
Dominovas Energy (DNRG)

Balance Sheet ($MM)2010-06-302010-09-302010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash22228522214011658545845374336394138272379306446494379418516444207
Accounts Receivable1,4071,3661,5361,9452,1132,1882,0011,8031,9982,8242,7862,8421,4581,7771,3731,1651,1461,3971,4561,5551,8772,9143,0833,9463,1233,6843,6714,0094,3124,3494,368
Inventory3472062793152506705936056097306476076837638299349671,5201,5911,5891,4211,2561,5071,6771,7221,8321,814
PP&E2,2252,7322,7992,8273,1873,2343,2633,3453,4467,2677,9208,6859,78910,28710,82611,52712,00712,37512,80513,55114,48062,79065,73567,69969,16469,63770,96679,28080,29581,85683,537
Assets3,5814,1114,1884,6635,5305,4775,3215,1885,43512,93313,45414,16113,82414,69814,66215,48916,05416,79917,27118,84919,93674,21977,01177,96577,49578,57079,15688,44294,74894,97795,247
Accounts Payable1,5771,4331,5912,0042,1162,1112,0861,8621,9802,9152,9122,8871,6321,8881,3341,2511,3421,5711,5071,7502,0172,9003,4104,1263,2883,4883,3813,4913,9653,6453,519
Long-Term Debt1,2131,2481,1291,1801,6981,7001,5831,5591,6291,5892,3853,0763,3723,6444,1604,4634,6254,9505,6306,0076,1506,0577,3566,80233,39034,34034,28033,51033,90033,85040,69846,40046,38046,730
Liabilities2,9173,0753,1463,6224,3484,2834,0913,8624,0416,6046,9557,1286,6247,0566,8797,6337,9598,3648,2879,8419,61548,60350,34549,69643,41044,53444,48059,72458,46558,62959,636
Stockholders' Equity6641,0361,0421,0412,8352,6809,6928,66025,61626,66628,26928,00227,86528,34228,71828,23928,34227,637
Income Statement ($MM)2010-06-302010-09-302010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Revenue2,0381,8834362,2602,850513,4143,3183,2184,4774,8214,9152,5723,2022,4072,3051,7772,2682,1891293,7026,5766,9738,6108,2809,4109,64113,12113,87713,495
Cost of Revenue-1221,993-1946,7459,41510,3029,890
Gross Profit1733123232,8963,7063,5753,605
R&D
SG&A16162022232326303037273725252627262827293212010599112112123149175171
Tax44577888588657356881079-112-1,518069-611263555
Net Income511945950121791201761561251781706530795261842421942066372927611,0978796021,3581,2811,2811,224
Cash Flow ($MM)2010-06-302010-09-302010-12-312011-03-312011-09-302011-12-312012-03-312012-06-302012-09-302012-12-312013-03-312013-06-302013-09-302013-12-312014-03-312014-06-302014-09-302014-12-312015-03-312015-06-302015-09-302015-12-312016-03-312016-06-302016-09-302016-12-312017-03-312017-06-302017-09-302017-12-312018-03-312018-06-302018-09-302018-12-312019-03-312019-06-302019-09-30
Cash Operating612536215184102170107346105381881853011762551533605851,5331,6871,1481,7744,7912,1501,8462,1742,042
Cash Investing-280-70-28-91212-207-33230-665-814100-510-609-1,031328-543-443-1,471705-2,191-3,201-7861,841-3,432-1,476-1,098-1,844-1,481
Cash Financing219-18322-12741-41646912956517333264117224672812931,11335731,621-435407-1,171-789-650-402-798